Clinical Trial Update: Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis [Phase 4]

View source ↗

Summary

This clinical trial update describes a Phase 4 study of the fluocinolone acetonide intravitreal implant 0.18 mg for chronic noninfectious posterior segment uvei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noninfectious Posterior Uveitis

Drugs mentioned

• Iluvien (fluocinolone acetonide intravitreal implant) 0.18 mg (fluocinolone acetonide intravitreal implant)

Snippet

Sponsor: Alimera Sciences | Conditions: Uveitis, Posterior | Phase 4 | Status: ACTIVE_NOT_RECRUITING